| Name | Title | Contact Details |
|---|
TheraNova is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Argentum is the leading national trade association serving companies that own, operate, and support professionally managed senior living communities in the United States.
Grant and Associates is a Olympia, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
APER Solutions is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.